-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Biora Therapeutics' Debt Overview
Biora Therapeutics' Debt Overview
Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) decreased by 61.54%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials. One key aspect of a companies financials is its debt, but before we understand the importance of debt, let's look at how much debt Biora Therapeutics has.
Biora Therapeutics Debt
Based on Biora Therapeutics's financial statement as of November 14, 2022, long-term debt is at $127.44 million and current debt is at $0, amounting to $127.44 million in total debt. Adjusted for $37.06 million in cash-equivalents, the company's net debt is at $90.39 million.
Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents includes cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.
Shareholders look at the debt-ratio to understand how much financial leverage a company has. Biora Therapeutics has $62.61 million in total assets, therefore making the debt-ratio 2.04. Generally speaking, a debt-ratio more than 1 means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. For example, a debt ratio of 40% might be higher for one industry, but normal for another.
Importance of Debt
Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.
However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.
Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. Click here to learn more.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) decreased by 61.54%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials. One key aspect of a companies financials is its debt, but before we understand the importance of debt, let's look at how much debt Biora Therapeutics has.
在过去的三个月中,Biora Therapeutics Inc.(纳斯达克股票代码:BIOR)的股价下跌了61.54%。在了解公司在3个月等时间段内的价格变化时,查看其财务状况可能会有所帮助。公司财务状况的一个关键方面是债务,但在我们了解债务的重要性之前,让我们来看看Biora Therapeutics有多少债务。
Biora Therapeutics Debt
Biora Therapeut
Based on Biora Therapeutics's financial statement as of November 14, 2022, long-term debt is at $127.44 million and current debt is at $0, amounting to $127.44 million in total debt. Adjusted for $37.06 million in cash-equivalents, the company's net debt is at $90.39 million.
根据Biora Therapeutics截至2022年11月14日的财务报表,长期债务为1.2744亿美元,流动债务为0美元,总债务为1.2744亿美元。经3,706万美元现金等价物调整后,该公司的净负债为9,039万美元。
Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents includes cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.
让我们定义一下我们在上面段落中使用的一些术语。 当前债务 是公司在1年内到期的债务部分,而 长期债务 是 1 年以上到期的部分。 现金等价物 包括现金和任何到期期不超过 90 天的流动证券。 债务总额 等于当前债务加上长期债务减去现金等价物。
Shareholders look at the debt-ratio to understand how much financial leverage a company has. Biora Therapeutics has $62.61 million in total assets, therefore making the debt-ratio 2.04. Generally speaking, a debt-ratio more than 1 means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. For example, a debt ratio of 40% might be higher for one industry, but normal for another.
股东通过查看债务比率来了解公司有多少财务杠杆作用。Biora Therapeutics的总资产为6,261万美元,因此债务比率为2.04。一般而言,债务比率超过1意味着很大一部分债务由资产提供资金。随着债务比率的增加,如果利率上升,拖欠贷款的风险也随之增加。不同的行业对负债比率的容忍阈值不同。例如,一个行业的债务比率为40%可能更高,但对另一个行业来说是正常的。
Importance of Debt
债务的重要性
Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.
债务是公司资本结构中的重要因素,可以帮助其实现增长。债务的融资成本通常相对低于股权,这使其成为高管的有吸引力的选择。
However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.
但是,利息支付义务可能会对公司的现金流产生不利影响。拥有财务杠杆还使公司能够将额外资本用于业务运营,从而使股权所有者能够保留债务资本产生的超额利润。
Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. Click here to learn more.
正在寻找负债与权益比率低的股票?看看Benzinga Pro,这是一个市场研究平台,它为投资者提供了近乎即时的数十种股票指标,包括债务与权益比率。点击此处了解更多信息。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧